Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03912818
Title Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Stanford University

bladder urothelial carcinoma

bladder squamous cell carcinoma

bladder adenocarcinoma


Cisplatin + Durvalumab + Gemcitabine

Cisplatin + Doxorubicin + Durvalumab + Methotrexate + Vinblastine

Carboplatin + Durvalumab + Gemcitabine

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.